Lung‐Targeted Rnai Therapeutics: Lung‐Endothelium‐Targeted Nanoparticles Based on a pH‐Sensitive Lipid and the GALA Peptide Enable Robust Gene Silencing and the Regression of Metastatic Lung Cancer (Adv. Funct. Mater. 18/2019)
Abstract
Research context
OpenAlex topics: RNA Interference and Gene Delivery · Advanced biosensing and bioanalysis techniques · RNA modifications and cancer
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Laboratory of Innovative Nanomedicine Faculty of Pharmaceutical Sciences Hokkaido University Kita‐12, Nishi‐6, Kita‐ku Sapporo Hokkaido 060‐0812 Japan
Department of Pharmaceutics Faculty of Pharmacy Assiut University Assiut 71526 Egypt
Department of Histology and Cytology Faculty of Veterinary Medicine Zagazig University Zagazig 44511 Egypt
Laboratory of Anatomy Department of Biomedical Sciences Graduate School of Veterinary Medicine Hokkaido University Kita 18, Nishi 9, Kita‐ku Sapporo 060‐0818 Japan
Formulation Research Lab. Taiho Pharmaceutical Co., Ltd. 224‐2, Ebisuno, Hiraishi, Kawauchi‐cho Tokushima 771‐0194 Japan
Laboratory for Molecular Design of Pharmaceutics Faculty of Pharmaceutical Sciences Hokkaido University Sapporo Hokkaido 060‐0812 Japan
References
Reference metadata was not supplied for this record.